Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Paragon 28, Inc.

FNANYSE
Healthcare
Medical - Devices
$13.09
$0.00(0.00%)
U.S. Market is Open • 12:30

Paragon 28, Inc. Fundamental Analysis

Paragon 28, Inc. (FNA) shows moderate financial fundamentals with a PE ratio of -46.49, profit margin of -17.50%, and ROE of -17.38%. The company generates $0.1B in annual revenue with strong year-over-year growth of 18.39%.

Key Strengths

PEG Ratio-3.13
Current Ratio3.51

Areas of Concern

ROE-17.38%
Operating Margin-11.10%
Cash Position3.17%
We analyze FNA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 9.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
9.2/100

We analyze FNA's fundamental strength across five key dimensions:

Efficiency Score

Weak

FNA struggles to generate sufficient returns from assets.

ROA > 10%
-8.07%

Valuation Score

Excellent

FNA trades at attractive valuation levels.

PE < 25
-46.49
PEG Ratio < 2
-3.13

Growth Score

Moderate

FNA shows steady but slowing expansion.

Revenue Growth > 5%
18.39%
EPS Growth > 10%
5.71%

Financial Health Score

Excellent

FNA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.85
Current Ratio > 1
3.51

Profitability Score

Weak

FNA struggles to sustain strong margins.

ROE > 15%
-1737.51%
Net Margin ≥ 15%
-17.50%
Positive Free Cash Flow
No

Key Financial Metrics

Is FNA Expensive or Cheap?

P/E Ratio

FNA trades at -46.49 times earnings. This suggests potential undervaluation.

-46.49

PEG Ratio

When adjusting for growth, FNA's PEG of -3.13 indicates potential undervaluation.

-3.13

Price to Book

The market values Paragon 28, Inc. at 8.35 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.35

EV/EBITDA

Enterprise value stands at -145.57 times EBITDA. This is generally considered low.

-145.57

How Well Does FNA Make Money?

Net Profit Margin

For every $100 in sales, Paragon 28, Inc. keeps $-17.50 as profit after all expenses.

-17.50%

Operating Margin

Core operations generate -11.10 in profit for every $100 in revenue, before interest and taxes.

-11.10%

ROE

Management delivers $-17.38 in profit for every $100 of shareholder equity.

-17.38%

ROA

Paragon 28, Inc. generates $-8.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-8.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Paragon 28, Inc. generates limited operating cash flow of $-5.97M, signaling weaker underlying cash strength.

$-5.97M

Free Cash Flow

Paragon 28, Inc. generates weak or negative free cash flow of $-13.04M, restricting financial flexibility.

$-13.04M

FCF Per Share

Each share generates $-0.16 in free cash annually.

$-0.16

FCF Yield

FNA converts -1.18% of its market value into free cash.

-1.18%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-46.49

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-3.13

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.35

vs 25 benchmark

P/S Ratio

Price to sales ratio

8.19

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.85

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.51

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.17

vs 25 benchmark

ROA

Return on assets percentage

-0.08

vs 25 benchmark

ROCE

Return on capital employed

-0.06

vs 25 benchmark

How FNA Stacks Against Its Sector Peers

MetricFNA ValueSector AveragePerformance
P/E Ratio-46.4929.43 Better (Cheaper)
ROE-17.38%800.00% Weak
Net Margin-17.50%-20145.00% (disorted) Weak
Debt/Equity0.850.30 Weak (High Leverage)
Current Ratio3.514.64 Strong Liquidity
ROA-8.07%-17936.00% (disorted) Weak

FNA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Paragon 28, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

120.98%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-1706.99%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-302.37%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ